HGF and hepatocellular carcinoma: Sorafenib-resistant HCC cells were demonstrated to secrete HGF to activate c-Met receptors in an autocrine fashion, which ultimately results in sustained oncogenic signals, and these cells displayed elevated expression of mesenchymal proteins with enhanced invasive ability [36].